Covalent Modification of CDK2 by 4-Hydroxynonenal as a Mechanism of Inhibition of Cell Cycle Progression

Jeannie M. Camarillo, Kristie L. Rose, James J. Galligan, Shu Xu, Lawrence J. Marnett

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Oxidative stress is a contributing factor in a number of chronic diseases, including cancer, atherosclerosis, and neurodegenerative diseases. Lipid peroxidation that occurs during periods of oxidative stress results in the formation of lipid electrophiles, which can modify a multitude of proteins in the cell. 4-Hydroxy-2-nonenal (HNE) is one of the most well-studied lipid electrophiles and has previously been shown to arrest cells at the G1/S transition. Recently, proteomic data have shown that HNE is capable of covalently modifying CDK2, the kinase responsible for the G1/S transition. Here, we identify the sites adducted by HNE using recombinant CDK2 and show that HNE treatment suppresses the kinase activity of the enzyme. We further identify sites of adduction in HNE-treated intact human colorectal carcinoma cells (RKO) and show that HNE-dependent modification in cells is long-lived, disrupts CDK2 function, and correlates with a delay of progression of the cells into S-phase. We propose that adduction of CDK2 by HNE directly alters its activity, contributing to the cell cycle delay.

Original languageEnglish (US)
Pages (from-to)323-332
Number of pages10
JournalChemical Research in Toxicology
Volume29
Issue number3
DOIs
StatePublished - Mar 21 2016
Externally publishedYes

ASJC Scopus subject areas

  • Toxicology

Fingerprint

Dive into the research topics of 'Covalent Modification of CDK2 by 4-Hydroxynonenal as a Mechanism of Inhibition of Cell Cycle Progression'. Together they form a unique fingerprint.

Cite this